Skip to main content
. 2012 Aug 8;96(4):874–881. doi: 10.3945/ajcn.112.037267

TABLE 2.

RRs of colorectal cancer by total vitamin B-6 intake in the Nurses’ Health Study (1980–2008)1

Quintiles of intake
1 2 3 4 5 P-trend
Baseline
 No. of cases (n = 1614) 324 329 400 260 301
 Model 1 1.0 (reference)2 0.85 (0.73, 0.99) 0.91 (0.78, 1.05) 0.73 (0.62, 0.86) 0.73 (0.63, 0.86) <0.001
 Model 2 1.0 (reference) 0.87 (0.74, 1.01) 0.94 (0.81, 1.09) 0.78 (0.66, 0.91) 0.79 (0.67, 0.93) 0.01
 Model 3 1.0 (reference) 0.86 (0.73, 1.02) 0.95 (0.80, 1.14) 0.83 (0.65, 1.04) 0.84 (0.66, 1.07) 0.45
Cumulative average
 No. of cases (n = 1614) 320 360 328 303 303
 Model 1 1.0 (reference) 0.96 (0.83, 1.12) 0.84 (0.72, 0.98) 0.77 (0.66, 0.91) 0.78 (0.66, 0.91) 0.003
 Model 2 1.0 (reference) 1.03 (0.89, 1.20) 0.96 (0.82, 1.12) 0.90 (0.77, 1.06) 0.92 (0.79, 1.08) 0.22
 Model 3 1.0 (reference) 0.98 (0.82, 1.17) 0.91 (0.74, 1.12) 0.95 (0.76, 1.19) 1.00 (0.80, 1.24) 0.55
Simple update (0–4-y lag)
 No. of cases (n = 1375) 319 283 281 247 245
 Model 1 1.0 (reference) 0.87 (0.74, 1.02) 0.81 (0.69, 0.95) 0.71 (0.60, 0.84) 0.70 (0.59, 0.83) <0.001
 Model 2 1.0 (reference) 0.92 (0.78, 1.08) 0.89 (0.76, 1.05) 0.81 (0.68, 0.96) 0.80 (0.67, 0.95) 0.02
 Model 3 1.0 (reference) 0.95 (0.80, 1.13) 1.00 (0.81, 1.23) 0.94 (0.74, 1.19) 0.92 (0.73, 1.16) 0.52
4–8-y lag
 No. of cases (n = 1249) 270 262 256 226 235
 Model 1 1.0 (reference) 0.95 (0.80, 1.13) 0.85 (0.72, 1.01) 0.77 (0.64, 0.91) 0.79 (0.67, 0.95) 0.02
 Model 2 1.0 (reference) 0.99 (0.83, 1.17) 0.92 (0.77, 1.09) 0.85 (0.71, 1.01) 0.88 (0.74, 1.05) 0.17
 Model 3 1.0 (reference) 0.96 (0.80, 1.16) 0.92 (0.75, 1.14) 0.97 (0.75, 1.25) 0.99 (0.78, 1.26) 0.73
8–12-y lag
 No. of cases (n = 1065) 234 238 217 203 173
 Model 1 1.0 (reference) 0.99 (0.83, 1.19) 0.84 (0.69, 1.01) 0.80 (0.66, 0.97) 0.68 (0.55, 0.83) <0.001
 Model 2 1.0 (reference) 1.03 (0.86, 1.24) 0.89 (0.74, 1.08) 0.89 (0.73, 1.08) 0.75 (0.62, 0.92) 0.002
 Model 3 1.0 (reference) 1.10 (0.90, 1.34) 1.03 (0.82, 1.29) 1.09 (0.83, 1.44) 0.92 (0.71, 1.21) 0.17
12–16-y lag
 No. of cases (n = 770) 203 176 177 168 146
 Model 1 1.0 (reference) 0.82 (0.66, 1.02) 0.75 (0.61, 0.93) 0.77 (0.62, 0.96) 0.66 (0.53, 0.83) 0.004
 Model 2 1.0 (reference) 0.85 (0.68, 1.06) 0.79 (0.64, 0.98) 0.85 (0.68, 1.06) 0.74 (0.59, 0.92) 0.045
 Model 3 1.0 (reference) 0.91 (0.72, 1.15) 0.89 (0.68, 1.15) 1.04 (0.76, 1.42) 0.93 (0.69, 1.26) 0.71
1

Model 1 was adjusted for age (mo). Model 2 was adjusted as for model 1 and for smoking before age 30 y (0, 1–4, 5–10, or >10 pack-years), history of colorectal cancer in a parent or sibling (yes or no), history of endoscopy (yes or no), regular aspirin use (yes or no), BMI (in kg/m2; <25, 25 to <30, or ≥30), physical activity (<3, 3 to <27, or ≥27 metabolic equivalent task hours per week), and postmenopausal hormone use (premenopausal, never, past, or current user). Model 3 was adjusted as for model 2 and for consumption of processed meat (quintiles), alcohol consumption (0 to <5, 5 to <10, 10 to <15, or ≥15 g/d), energy-adjusted total calcium intake (quintiles), total folate (quintiles), total vitamin D intake (quintiles), and total energy intake (quintiles). P-trend values were calculated by using Wald's test.

2

RR; 95% CI in parentheses (all such values).